日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant relatlimab and nivolumab in resectable melanoma

可切除黑色素瘤的新辅助治疗 relatlimab 和 nivolumab

Rodabe N Amaria #, Michael Postow #, Elizabeth M Burton #, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam, Lauren Simpson, Jennifer L McQuade, Michael K Wong, Jeffrey E Gershenwald, Jeffrey E Lee, Ryan P Goepfert, Emily Z Keung, Sar

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

高危可切除黑色素瘤的新辅助免疫检查点阻断疗法

Rodabe N Amaria ,Sangeetha M Reddy ,Hussein A Tawbi ,Michael A Davies ,Merrick I Ross ,Isabella C Glitza ,Janice N Cormier ,Carol Lewis ,Wen-Jen Hwu ,Ehab Hanna ,Adi Diab ,Michael K Wong ,Richard Royal ,Neil Gross ,Randal Weber ,Stephen Y Lai ,Richard Ehlers ,Jorge Blando ,Denái R Milton ,Scott Woodman ,Robin Kageyama ,Daniel K Wells ,Patrick Hwu ,Sapna P Patel ,Anthony Lucci ,Amy Hessel ,Jeffrey E Lee ,Jeffrey Gershenwald ,Lauren Simpson ,Elizabeth M Burton ,Liberty Posada ,Lauren Haydu ,Linghua Wang ,Shaojun Zhang ,Alexander J Lazar ,Courtney W Hudgens ,Vancheswaran Gopalakrishnan ,Alexandre Reuben ,Miles C Andrews ,Christine N Spencer ,Victor Prieto ,Padmanee Sharma ,James Allison ,Michael T Tetzlaff ,Jennifer A Wargo

Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis

使用多模光谱诊断对非侵入性体内黑色素瘤和非黑色素瘤皮肤癌进行临床研究

Liang Lim, Brandon Nichols, Michael R Migden, Narasimhan Rajaram, Jason S Reichenberg, Mia K Markey, Merrick I Ross, James W Tunnell

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

前瞻性多中心 II 期临床试验,评估 ADH-1 与马法兰联合通过肢体单独输注治疗晚期肢体黑色素瘤患者

Georgia M Beasley, Jonathan C Riboh, Christina K Augustine, Jonathan S Zager, Steven N Hochwald, Stephen R Grobmyer, Bercedis Peterson, Richard Royal, Merrick I Ross, Douglas S Tyler

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

2,313 名 III 期黑色素瘤患者预后因素的多变量分析:淋巴结微转移与大转移的比较

Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Shouluan Ding, David R Byrd, Natale Cascinelli, Alistair J Cochran, Daniel G Coit, Alexander M Eggermont, Timothy Johnson, John M Kirkwood, Stanley P Leong, Kelly M McMasters, Martin C Mihm Jr, Donald L Morton, Merrick I Ross, 

Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial

粒细胞/巨噬细胞集落刺激因子对多肽黑色素瘤疫苗循环 CD8+ 和 CD4+ T 细胞反应的影响:一项多中心随机试验的结果

Craig L Slingluff Jr, Gina R Petroni, Walter C Olson, Mark E Smolkin, Merrick I Ross, Naomi B Haas, William W Grosh, Marc E Boisvert, John M Kirkwood, Kimberly A Chianese-Bullock

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma

局部晚期转移性恶性黑色素瘤患者通过肢体单独输注系统性 ADH-1 与美法仑联合治疗的 1 期临床研究

Georgia M Beasley, Nicole McMahon, Gretchen Sanders, Christina K Augustine, Maria A Selim, Bercedis Peterson, Robin Norris, William P Peters, Merrick I Ross, Douglas S Tyler